ID   WILL-1
AC   CVCL_1900
SY   WILL1
DR   BioSample; SAMN03473464
DR   DSMZ; ACC-651
DR   DSMZCellDive; ACC-651
DR   GEO; GSM1374989
DR   Wikidata; Q54994082
RX   PubMed=18972186;
CC   Population: Japanese.
CC   Doubling time: ~30-50 hours, 50-70 hours (Note=After recovery from liquid nitrogen freezing) (DSMZ=ACC-651).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-651
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 14,22
ST   D19S433: 13,14
ST   D21S11: 28,32.2
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 9,13
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
RX   PubMed=18972186; DOI=10.1007/s12185-008-0189-x;
RA   Uneda S., Gotoh M., Sonoki T., Nishida K., Nakamura Y., Kurimoto M.,
RA   Hanaoka N., Matsuoka H., Taniwaki M., Nakakuma H.;
RT   "Establishment of CD5 and CD10 double-positive mature B-cell line,
RT   WILL1, showing complex 8q24 translocation involving 14q32 and 6q27.";
RL   Int. J. Hematol. 88:536-542(2008).
//